In contrast to these findings, myostatin has been demonstrated as a negative regulator of bone in older subjects74 whereas irisin was shown to be associated with reduced risk of osteoporosis in postmenopausal women (for a review see75). The gene discussed is MSTN; the disease is osteoporosis.